MedWatch

New investors for Fluxome by summer

Fluxome Sciences expects to welcome new foreign investors on board by this summer. A recent nomination for a prestigious award is expected to help boost interest.

Foto: Colourbox/JP

The biotech company Fluxome Sciences A/S - which is currently launching a food supplement product, the substance of which is known as the health beneficial part of red wine – has recently been nominated for the prestigious 2012 Red Herring 100 Europe Award.

The chairman hopes that the nomination from the global media company can help them in on-going negotiations about a possible capital injection.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier